Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Phase II Trial of Silymarin for Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis
Phase 2
Completed
- Conditions
- Non-alcoholic Steatohepatitis
- Interventions
- Drug: Silymarin 420 mgDrug: Silymarin 700 mgOther: Placebo
- First Posted Date
- 2008-05-20
- Last Posted Date
- 2019-07-17
- Lead Sponsor
- Madaus Inc
- Target Recruit Count
- 78
- Registration Number
- NCT00680407
- Locations
- 🇺🇸
Beth Isreal Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States
🇺🇸University of Pennsylvania, Philadelphia, Pennsylvania, United States
News
No news found